NKWO Therapeutics is an internationally recognized Clinical Research Organization specializing in Phase 1 through Phase IV clinical trials for biologics, drugs, and medical devices. Our sponsor are from all around the globe, including Asia, Europe, Australia, and North America. NKWO Therapeutics Clinical Research Institute was initially founded to achieve research excellence in the lower extremity area, including gene therapy. We are passionate about promoting high-quality research in pharmaceuticals, medical devices, and advanced medicine. NKWO Therapeutics Clinical Research Institute's network of expert clinical research facilities, highly experienced operations and administrative staff, and collaborative partnerships promotes a seamless overall trial experience. NKWO Therapeutics is committed to improve the health and well-being of many across the globe through high quality clinical research.
